Each year in June, Clarivate Analytics publish the Journal Impact Factors of all journals indexed in the Journal Citation Report.

The 2018 Journal Impact Factor for CDSR is 7.755, which describes the ratio of the number of citations in 2018 of reviews published in 2016 and 2017 (12,106) to the number of reviews published in 2016 and 2017 (1,561).

The 2018 CRG Impact Factor for the Cochrane Infectious Diseases Group (CIDG) is 7.462 (26 publications cited 194 times). A review published by the CIDG in 2016 and 2017 was cited, on average, 7.462 times in 2018.

The 10 most cited reviews from the Infectious Diseases Group contributing to the 2018 Impact Factor were:

1.      Corticosteroids for managing tuberculous meningitis

2.      Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV

3.      Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection

4.      School-based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents

5.      Nutritional supplements for people being treated for active tuberculosis

6.      Oral iron supplements for children in malaria-endemic areas

7.      Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever

8.      GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs

9.      Mefloquine for preventing malaria during travel to endemic areas

10.   Oral zinc for treating diarrhoea in children

The 10 most accessed Cochrane Systematic Reviews for Infectious Diseases Group in 2018 were:

1.      Ivermectin and permethrin for treating scabies

2.      Treatment of enteric fever (typhoid and paratyphoid fever) with third and fourth generation cephalosporins

3.      Probiotics for treating acute infectious diarrhoea

4.      School-based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents

5.      Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever

6.      Hand washing promotion for preventing diarrhoea

7.      Oral zinc for treating diarrhoea in children

8.      Interventions to increase tuberculosis case detection at primary healthcare or community-level services

9.      Psychosocial group interventions to improve psychological well-being in adults living with HIV

10.   Combined and alternating paracetamol and ibuprofen therapy for febrile children

The CIDG editorial is funded by UK aid from the UK government for the benefit of low- and middle-income countries (project number 300342-104). The views expressed do not necessarily reflect the UK government’s official policies